Τόμος 14 (2000) – Τεύχος 3 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 14 (2000) – Issue 3 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1.       Technological Educational Institution of Athens, Athens, Greece

2.      Department of Nursing, University of Athens, Athens, Greece

Accepted for publication: 20 June 2000

pharmakonpress[at]pharmakonpress[.]gr

2.    Gallen B.A.: Acne vulgaris. Lippincotts Prim. Care Pract. 7: 88-92(1997)

3.    Jansen T., Burgdorf W.H., Piewing G.: Pathogenesis and treatment of acne in childhood. Pediatr. Dermatol. 14: 17-21 (1997)

4.    Brown S.K., Shalita A.R.: Acne vulgaris. Lancet. 351: 1871-1876 (1998)

5.    Jansen T., Piewing G.: Advances and perspectives in acne therapy. Eur. J. Med. Res. 2: 321-334 (1997)

6.    Stathakis V., Kilkenny M., Marks R.: Descriptive epidemiology of acne vulgaris in the community. Australas J. Dermatol. 38: 115-123 (1997)

7.    Faure M.: Acne. Etiology, physiopathology, diagnosis, treatment. Rev. Prat. 46: 887-892 (1996)

8.    Black P.A.: Acne vulgaris. Prof. Nurse. 11: 181-183 (1995)

9.    Webster G.F.: Inflammation in acne vulgaris. J. Am. Acad. Dermatol. 33: 247-253 (1995)

10.  Rothman K.F., Lucky A.W.: Acne vulgaris. Adv. Dermatol. 8: 347-374 (1993)

11.  Faure M.: Acne. Etiology, physiopathology, diagnosis, treatment. Rev. Prat. 43: 1301-1305 (1993)

12.  Janniger C.K.: Neonatal and infantile acne vulgaris. Cutis 52: 16 (1993)

13.  Rossen M.H., Roed Petersen J.: Acne vulgaris. Ugerskr. Laeger. 155: 775-778 (1993)

14.  Matsuoka L.Y.: Acne and related disorders, Clin. Plast. Surg. 20: 35-41 (1993)

15.  Millikan L.E., Shrum J.P.: An update on common skin diseases. Acne, psoriasis, contact dermatitis and warts. Postgrad. Med. 91: 96-98, 101-104, 107-110 (1992)

16.  Sehgal V.N., Jain S.: Acne and acneiform dermatoses. J. Indian. Med. Assoc. 89: 80-81 (1991)

17.  Kligman A.M.: Postmenopausal acne. Cutis 47: 425- 426(1991)

18.  Leung A.K., Robson W.L.: Acne. J.R. Soc. Health. 712: 57-60(1991)

19.  Webster G.F.: Inflammatory acne. Int. J. Dermatol. 29: 317-319 (1990)

20.  Amblard P.: Acne. Physiopathology, clinical aspects, treatment. Rev. Prat. 40: 662-664 (1990)

21.  Leyden J.J.: New understandings of pathogenesis of acne. J. Am. Acad. Dermatol. 32: 15-25 (1995)

22.  Gollnick H., Schramm M.: Topical therapy in acne. J. Eur. Acad. Dermatol. Venereol. 11: 8-12 (1998)

23.  Van Hoogdalem E.J.: Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. J. Eur. Acad. Dermatol. Venereol. 11: 13-19 (1998)

24.  Cunliffe W.J.; Management of adult acne and acne variants. J. Cutan. Med. Surg. 2: 7-13 (1998)

25.  Marcoux D., Mc Cuaig C.C., Powell J.: Prepubertal acne: clinical presentation, evaluation and treatment. J. Cutan. Med. Surg. 2: 2-6 (1998)

26.  Miller R.A.: Side effects of acne therapy and their management. J. Cutan. Med. Surg. 2: 14-18 (1998)

27.  De Grood H.E., Friedlander S.F.: Update on acne. Curr. Opin. Pediatr. 10: 381-386 (1998)

28.  Boston M.: Acne: avoiding permanent damage. Com-munity Nurse 3: 15-16 (1997)

29.  Leyden J.J.: Topical treatment of acne vulgaris: retinoids and cutaneous irritation. J. Am. Acad. Dermatol. 38: 1-4 (1998)

30.  Usatine R.P., Qluan M.A., Strick R.: Acne vulgaris: a treatment update. Hosp. Pract. Off. Ed. 33:111-117, 121- 124, 127(1998)

31.  Schmidt J.B., Fanta D.: 13 – cis retinoic acid an effective therapy for acne conglobata. 2. Hautkr. 59: 279-287 (1984)

32.  Gibson J.R.: Rationale for development of new topical treatments for acne vulgaris. Cutis 57: 13-19 (1996)

33.  Berson D.S., Shalita A.R.: The treatment of acne: the role of combination therapies. J. Am. Acad. Dermatol. 32: 31-41 (1995)

34.  Webster G.F.: Topical tretinoin in acne therapy. J. Am. Acad. Dermatol. 39: 38-48 (1998)

35.  Schmidt J.B., Neumann R., Fanta D., Raab W. 1 sent per clindamycin phosphate solution versus 5 per cent benzoyl peroxide gel in papulopustular acne. Z Hautkr. 63: 374-376 (1988)

36.  Fanta D., Muller M.M.: Effect of benzoyl peroxide on skin surface lipids. Dermatogica 158: 55-59 (1979)

37.  Webster G.F.: Inflammation in acne vulgaris. J. Am. Acad. Dermatol. 33: 247-253 (1995)

38.  Munro C.S.: Acne. J.R. Coll. Physicians. Lond. 31: 360-363 (1997)

39.  O’ Loughlin S.: Treatment of acne. Ir. Med. J. 88: 114- 115 (1995)

40.  Fanta D., Scholz N.: Miconazol – Benzoyl peroxid: eine neue kombination zur Erweiterung der lokalen Aknetherapie. Z Hautkr. 59: 873-881 (1984)

41.  Weiss J.S.: Current options for topical treatment of acne vulgaris. Pediatr. Dermatol. 14: 480-488 (1997)

42.  Weiss J.S., Shavin J.S.: Adapatene for treatment of acne vulgaris. J. Am. Acad. Dermatol. 39: 50-54 (1998)

43.  Gibson J.R.: Azelaic acid 20% cream and the medical management of acne. Dermatol. Nurs. 9: 339-344 (1997)

44.  Solomon B.A., Shalita A.R.: Effects of detergents on acne. Clin. Dermatol. 14: 95-99 (1996)

45.  Mackrides P.S., Shaughnessy A.F.: Azelaic acid therapy for acne. Am. Fam. Physician. 54: 2457-2459 (1996)

46.  Nguyen Q. H., Bui T.P.: Azelaic acid: pharmakokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int. J. Dermatol. 34: 75-84 (1995)

47.  Gibson J.R.: Benzamycin gel for acne. Drug. Then Bull. 33: 62-64 (1995)

48.  Cooper A.J.: Systemic review of Propionibacterium acnes resistance to systemic autibiotics. Med. J. Aust. 169: 259-261 (1998)

49.  Taffe A.M.: Acne treatment. A comprehensive review of pharmacotherapy. Lippincotts. Prim. Care. Pract. 1: 70- 87 (1997)

50.  Brogden R.N., Goa K.E.: Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 53: 511-519 (1997)

51.  Leyden J.J.: Therapy for acne vulgaris. N. Engl. J. Med. 336: 1156-1162 (1997)

52.  Parry E.J., Griffiths C.E.: Bacteria and antimicrobial agents in the treatment of acne. Int. J. Dermatol. 35: 249- 251 (1996)

53.  Thiboutot D.M.: An overview of acne and its treatment. Cutis 57: 8-12 (1996)

54.  Lee A.G.: Pseudotumor celebri after treatment with tetracycline and isotretinoin for acne. Cutis 55: 165-168 (1995)

55.  Fanta D.: Clinical experiences with a new erythromycin – containing externally administered drug for treatment of acne. Z Hautkr. 55: 1528-1531 (1980)

56.  Redmond G.P.: Effectiveness of contraceptives in the treatment of acne. Contraception 58: 29-33 (1998)

57.  Cunliffe W.J.: Hormonal therapy for acne in women. J. Pediatr. Adolesc. Gynecol. 11: 157-159 (1998)

58.  Beylot C., Doutre M.S., Beylot – Barry M.: Oral contraceptives and cyproterone acetate in female acne treatment. Dermatology 196: 148-152 (1998)

59.  Baur D.A., Butler R.C.: Current concepts in the pathogenesis and treatment of acne. J. Oral. Maxillofac. Surg. 56: 651-655 (1998)

60.  Shaw J.C.: Antiandrogen and hormonal treatment of acne. Dermatol. Clin. 14: 803-811 (1996)

61.  Fanta D., Muller M.M.: Effect of cyproterone acetate on skin surface lipids. Acta Derm. Venereol. 58: 85-87 (1978).

62.  Fanta D., Schneider W.H., Spona J., Neufeld T.: Anti androgen treatment of acne. Wien. Klein. Wochenchr. 89: 622-627 (1977)

63.  Fanta D., Stoger H.: Hormonal therapy of acne vulgaris. Review and results of treatment. Wien. Klin. Wochenschr. 87: 158-163 (1975)

64.  Goodfellow A. et Al: Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br. J. Dermatol. 111: 209 (1984)

65.  Cusan L. et al.: Treatment of hirsutism with pure andiandrogen flutamide. J. Am. Acad. Dermatol. 23: 462 (1990)

66.  Chen W. et al.: The 5-alpha reductase system and its inhibitors: Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 193: 177(1996)

67.  Leyden J.J.: The role of isotretinoin in the treatment of acne: personal observations. J. Am. Acad. Dermatol. 39: 45-49 (1998)

68.  Coates, P., Adams C.A., Cunliffe W.J., Me Ginley K.T., Eady E.A., Leyden J.J., Ravenscroft J., Vyakrnam S., Vowels B.: Does oral isotretinoin prevent Propionibacterium acnes resistance? Dermatology 195: 4-9 (1997)

69.  Leyden J.J.: Oral isotretinoin. How can we treat difficult acne patients? Dermatology 195: 29-33 (1997)

70.  Horne H.L., Carmichael A.J.: Juvenile nodulocystic acne responding to systemic isotretinoin. Br. J. Dermatol. 136: 796-797(1997)

71.  Schmidt J.B., Fanta D.: 13 – cis retinoic acid an effective therapy for acne conglobata. Z Hautkr. 59: 279-287 (1984)

72.  Bertolucci L.E.: Introduction of any inflammatory drugs byiontoforesis: G. Ortho. Phys. Therap. 4: 104 (1982)

73.  Williams D.F. and Schmitt W.H.: Chemistry and Technology of the Cosmetics and Toiletries Industry. Chapman and Hall, London (1996)

74.  Wiecher J.W., Barlow T.: Skin moisturisation and elasticity originate from at least two different mechanisms. Int. J. Cosmet. Sci. 21: 425-435 (1999)

75.  Russo T., Landeryou V., Hall L.: Polyglycerol Esters, a new class of active skin moisturisers. Cosm. and Toil. Wld. 25: 142-148(1997)

76.  Chersetich I., Teofoli P., Gantcheva M., Ribuffo M., Puddu P.: Chemical peeling: how, when, why? J. Eur. Acad. Dermatol. 8: 1-11 (1997)

77.  Bridenstine J.B., Dolezal J.F.: Standardizing chemical peel solution formulations to avoid mishaps. J. Dermatol Surg. Oncol. 20: 813-816 (1994)

78.  Glogan RG., Matarasso SL.: Chemical peels. Dermatol. Clin. 13: 263-265 (1995)

79.  Abel E.A.: Phototherapy. Dermatol. Clin. 13: (4) 841- 849 (1995)

80.  Gilchrest B.A.: Mechanisms of ultraviolet light-induced pigmentation. Photochem. Photobiol. 63: 1 (1996)

81.  Taylor C.R., Stem R.S., Leyden J.T., GNcherst B.A.: Photoaging, photodamage and photoprotection. J. Am. Acad. Dermatol. 22: 1-15 (1990)

82.  Barlow T., Wiechers, J.W. Measuring skin hydration. Cosm. Toil. 114: 47-53 (1999)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr